Evidence map›Paper›PMID 42030006›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026

Stereotactic body radiation therapy (SBRT) practice patterns for spine metastases in Spain: a national survey by the SRS/SBRT SEOR (Spanish Society of Radiation Oncology) Working Group.

Rafael García, Maria José Pérez-Calatayud, Eva Corrales, Cristina Prieto, Sara Vázquez, Virginia García, Iñigo San Miguel, Carolina de la Pinta, Virginia Morillo, Jose Luis Monroy and 15 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Rafael García *Department of Radiation Oncology, Hospital Ruber Internacional, Madrid, Spain. rafael.garciag.ce@ruberinternacional.es.ORCID http://orcid.org/0000-0003-4679-1410
Maria José Pérez-CalatayudDepartment of Radiation Oncology, Hospital La Fe, Valencia, Spain.
Eva CorralesDepartment of Radiation Oncology, Hospital Universitario de Burgos, Burgos, Spain.
Cristina PrietoDepartment of Radiation Oncology, Hospital Universitario Torrecárdenas, Almeria, Spain.
Sara VázquezDepartment of Radiation Oncology, Hospital Universitario Arnau de Vilanova, Lleida, Spain.
Virginia GarcíaDepartment of Radiation Oncology, Hospital Universitario Arnau de Vilanova, Lleida, Spain.
Iñigo San MiguelDepartment of Radiation Oncology, Complejo Asistencial Universitario, Salamanca, Spain.
Carolina de la PintaDepartment of Radiation Oncology, Hospital Universitario Ramon y Cajal, Madrid, Spain.
Virginia MorilloDepartment of Radiation Oncology, Hospital Provincial Castellón, Castellón, Spain.
Jose Luis MonroyDepartment of Radiation Oncology, Hospital Universitario La Ribera Alzira, Valencia, Spain.
Marina PeñaDepartment of Radiation Oncology, Hospital Quiron Pozuelo, Madrid, Spain.
Luis SopeñaDepartment of Radiation Oncology, Hospital Universitario Lozano Blesa, Saragossa, Spain.
Beatriz QuilesDepartment of Radiation Oncology, Hospital Virgen de La Arrixaca, Murcia, Spain.
Héctor Pérez-MonteroDepartment of Radiation Oncology, Insitituto Catalan de Oncología, Barcelona, Spain.
Gonzalo RodríguezDepartment of Radiation Oncology, Hospital Universitario de Canarias, Tenerife, Spain.
Arturo NavarroDepartment of Radiation Oncology, Hospital Duran I Reynals, Barcelona, Spain.
María VeirasDepartment of Radiation Oncology, Centro Oncologico de Galicia, A Coruña, Spain.
Jesús BlancoDepartment of Radiation Oncology, Hospital Virgen del Rocio, Seville, Spain.
Paula BlascoDepartment of Radiation Oncology, Hospital Universitario Clínico San Cecilio, Granada, Spain.
Amalia PalaciosDepartment of Radiation Oncology, Hospital Reina Sofia, Córdoba, Spain.
Luis LarreaDepartment of Radiation Oncology, Hospital Vithas Virgen del Consuelo, Valencia, Spain.
Javier AristuDepartment of Radiation Oncology, Clinica Universitaria Navarra, Madrid, Spain.
José ExpósitoDepartment of Radiation Oncology, Hospital Universitario Virgen de Las Nieves, Granada, Spain.
Sergi BenaventeDepartment of Radiation Oncology, Hospital Vall d´Hebron, Barcelona, Spain.
Raquel Ciérvide *Department of Radiation Oncology, Hospital Universitario HM Sanchinarro, Madrid, Spain. raquel.ciervide@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThis study aims to evaluate the clinical practice in the treatment of spine metastases using stereotactic body radiation therapy (SBRT) among members of the SEOR (Spanish Society of Radiation Oncology) SRS/SBRT Working Goup to gather comprehensive data on clinical protocols, equipment usage, and treatment parameters. MATERIALS AND

methodsA 31-question electronic survey via Google Forms platform was distributed to members of the Working Group, with responses collected from 24 Spanish institutions, representing 1 per institution. This study aimed to assess demographic profiles, equipment, treatment protocols, immobilization techniques, dose and fractionation schedules, IGRT practices, and prescription criteria for spine SBRT.

resultsMost respondents (64.3%) were radiation oncologists with over 10 years of experience. The predominant equipment used was C-LINAC (85.7%). Most institutions (96.4%) had specific protocols for spine metastases management. The Spine Instability Neoplastic Score (SINS) was used by 85.7% of the surveyed for evaluating vertebral stability. According to the number of contiguous spine metastases treated, 81.5% treated up to two. Guidelines from Cox et al. and ESTRO were followed by 96.4% for intact spine metastases, with 81% adhering to Redmond et al. for adjuvant SBRT. Among the 24 surveyed centers, 32.1% used a single dose, 48.1% 2 fractions, 96.3% 3 fractions, and 74.1% 5 fractions. IGRT systems included CBCT (71.4%), X-ray (10.7%), and CBCT and X-ray (25%). The majority of responders (66.7%) indicated coverage of 95% of the PTV with 95-100% of the prescribed dose.

conclusionThis survey highlights significant variability in equipment, protocols, and practices for spine SBRT among Spanish institutions. Standardization of treatment approaches could enhance consistency and oncologic outcomes in spine SBRT.

Indexed as

Practice Patterns, Physicians'Radiation OncologyRadiosurgerySpinal NeoplasmsDose Fractionation, RadiationHumansRadiotherapy DosageSocieties, MedicalSpainSurveys and QuestionnairesLocal controlOligometastaticSBRTSpine metastases

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.